Vericel Corporation

VCEL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $26.9M $23.0M — — $8.1M $13.6M $5.5M $31.2M
Accounts Receivable $18.3M $17.1M $10.9M $8.2M $8.0K $28.0K $9.0K $25.0K
Inventory $3.8M $3.5M $1.4M $1.9M — — — —
Total Current Assets $50.5M $44.7M $27.3M $41.5M $8.5M $14.0M $6.2M $31.7M
Property, Plant & Equipment $4.1M $3.9M $4.0M $2.9M $739.0K $1.2M $1.6M $1.1M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — $0 $2.9M $3.2M — — — —
Total Assets $54.6M $48.6M $34.3M $47.6M $9.2M $15.2M $7.7M $32.8M
Liabilities
Accounts Payable $5.6M $6.5M $7.6M $5.8M $2.7M $2.8M $2.2M $2.9M
Total Current Liabilities $13.1M $12.9M $12.1M $11.8M $5.3M $5.7M $20.7M $29.9M
Long-Term Debt — — — — — $6.0K $40.0K $41.0K
Total Liabilities $32.0M $23.9M $12.2M $11.9M $5.3M $5.7M $20.7M $29.9M
Stockholders' Equity
Retained Earnings $-360.9M $-343.6M $-324.0M — $-287.8M $-275.3M $-241.8M $-222.2M
Total Stockholders' Equity $22.5M $24.7M $22.1M $35.6M $3.9M $-32.1M $-13.0M $2.9M
← Newer Page 2 of 2 Older →